VISIOPHARM A/S: Financial statements 2013
CVR: 26186676
Source: annual report 2013, Danish Business Authority
01/10/2012 – 30/09/2013
VISIOPHARM A/S (CVR 26186676) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 6,364,341 and a net result of DKK -796,604 compared with DKK -958,323 the year before. That is a decrease of 13.2% compared with the year before. Equity in the 2013 report amounted to DKK 5,521,246. The solvency ratio was 51.8%.
- Gross Profit
- DKK 6,364,341
- Profit/Loss
- DKK -796,604
- Equity
- DKK 5,521,246
- Total Assets
- DKK 10,667,395
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
VISIOPHARM A/S has published its annual report for 2012. Gross profit came to DKK 7,334,504, and the net result was DKK -958,323.
About VISIOPHARM A/S
VISIOPHARM A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2001. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The company was previously named VISIOPHARM ApS. The management consists of Johan Doré Hansen and Michael Grunkin. The board consists of Evis Hursever (chair), Andrew James Thomson and Per Fredrik Thorell. The company is owned by Neptune Denmark Holdco ApS. The company has 56 employees (2026). In 2025, the company reported revenue of DKK 130,617,000 and a net result of DKK -17,223,000 compared with DKK -17,363,000 the year before. Equity in the 2025 report amounted to DKK -4,949,000.